arrow
A

Andrea Swenson

university college london
H指数:27
被引数:4,189

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Establishing biomarkers and clinical endpoints in myotonic dystrophy type 1 (END-DM1): Protocol of an international natural history study

在强直性肌营养不良1型中建立生物标志物和临床终点(END-DM1):一项国际性自然病史研究的方案

2025-12-110
PRE
Shared burden of ultra-rare genetic variants across a spectrum of motor neuron diseases

超罕见遗传变异在一系列运动神经元疾病中的共享负担

2025-10-290
OAAI
Multicenter Expanded Access Protocol for Research Through Access to Trehalose in People With Amyotrophic Lateral Sclerosis

多中心扩展性访问方案:通过向肌萎缩侧索硬化症患者提供海藻糖进行研究

2025-08-260
OAAI
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis, A Randomized Clinical Trial

Zilucoplan治疗肌萎缩侧索硬化症的疗效与安全性:一项随机临床试验

2025-02-173
OA
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial
2022-05-1651
OAAI
Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathy
2022-01-2923
OAAI
Machine learning suggests polygenic risk for cognitive dysfunction in amyotrophic lateral sclerosis

机器学习提示肌萎缩性侧索硬化症认知功能障碍的多基因风险

2020-12-0311
OA
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis
2020-09-03345
OAAI
A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis
2016-07-0590
OAAI
A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progression

美新律在ALS中的随机试验: 安全性和对肌肉痉挛和进展的影响

2016-04-1963
OAAI
Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS cohort
2016-03-0169
PREAI